Induced Pluripotent Stem Cells: Production and Utility in Regenerative Medicine

Event details

6th October 2011
The Penridge Suite, 470 Bowes Road, London N11 1NL

About the event


The production of iPS cells from dermal fibroblasts has generated intense interest in the utility of such cells for research purposes and clinical applications. iPS cell production currently requires the use of transcription factor gene delivery to reprogramme cells into iPS cells. Hence, both gene delivery technology and iPS cell characterization and subsequent cell differentiation are critical aspects of iPS

cell biology. This meeting will address both issues